Conduits - The Institutes for Translational Sciences
The Institutes for Translational Sciences, known as Conduits, was established in 2009 when Icahn School of Medicine at Mount Sinai received a Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH). Conduits enables the translation of basic scientific discoveries into clinical practice at Mount Sinai by creating an effective, efficient and centralized administrative research structure. Its goals are to foster and reward interdisciplinary collaboration, educate and retain new clinical and translational investigators and deliver new therapies and an improved standard of care to Mount Sinai’s diverse community.
Conduits’ key programs include Biomedical Informatics; Community Engagement and Research; Translational Discoveries, which includes the Clinical Research Centers (CRC), the Office of Clinical Research (OCR), the Biostatistics, Epidemiology and Research Design (BERD) Program, and the Charles R. Bronfman Institute for Personalized Medicine (IPM); Experimental Therapeutics and Technology, which includes Experimental Therapeutics & Technologies (ETT), Pilot and Collaborative Translational and Clinical Studies, Shared Resource Facilities (SRFs) and the Translational and Molecular Imaging Institute (TMII); and Research Education, Training, and Career Development.